Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma This Viewpoint proposes that active surveillance should be evaluated as a management option for selected patients with low-risk and asymptomatic basal cell carcinoma. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma

JAMA Internal Medicine , Volume 181 (8) – Aug 14, 2021

Loading next page...
 
/lp/american-medical-association/active-surveillance-as-a-management-option-for-low-risk-basal-cell-XLIdjd7FoU
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2021.2643
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint proposes that active surveillance should be evaluated as a management option for selected patients with low-risk and asymptomatic basal cell carcinoma.

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Aug 14, 2021

References